Hyperfractionation for reirradiation of recurrent nasopharyngeal carcinoma.
作者信息
Chua Melvin L K, Lee Victor H F, Lee Anne W M
机构信息
Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology and Division of Medical Sciences, National Cancer Centre Singapore, Singapore; Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore.
Clinical Oncology Centre, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, China; Department of Clinical Oncology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
出版信息
Lancet. 2023 Mar 18;401(10380):878-879. doi: 10.1016/S0140-6736(23)00389-6. Epub 2023 Feb 23.
Abstract
摘要
相似文献
1
Hyperfractionation for reirradiation of recurrent nasopharyngeal carcinoma.
Lancet. 2023 Mar 18;401(10380):878-879. doi: 10.1016/S0140-6736(23)00389-6. Epub 2023 Feb 23.
2
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma.
Lancet Oncol. 2021 Jun;22(6):e217. doi: 10.1016/S1470-2045(21)00143-1.
3
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma.
Lancet Oncol. 2021 Jun;22(6):e218. doi: 10.1016/S1470-2045(21)00238-2.
4
Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
Head Neck. 2016 Apr;38 Suppl 1:E1102-9. doi: 10.1002/hed.24166. Epub 2015 Oct 9.
5
Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Acta Oncol. 2019 Sep;58(9):1238-1245. doi: 10.1080/0284186X.2019.1622772. Epub 2019 Jun 3.
6
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Head Neck. 2017 Mar;39(3):533-540. doi: 10.1002/hed.24645. Epub 2016 Nov 29.
7
Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma - Authors' reply.
Lancet Oncol. 2021 Jun;22(6):e219. doi: 10.1016/S1470-2045(21)00270-9.
8
Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.
Head Neck. 2020 Feb;42(2):180-187. doi: 10.1002/hed.25988. Epub 2019 Oct 16.
9
Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.
J Glob Oncol. 2019 Feb;5:1-14. doi: 10.1200/JGO.18.00191.
10
Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area.
Strahlenther Onkol. 2021 Mar;197(3):188-197. doi: 10.1007/s00066-020-01647-3. Epub 2020 Jun 8.
引用本文的文献
1
miRNA‑22‑3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1.
Oncol Lett. 2024 Dec 10;29(2):96. doi: 10.3892/ol.2024.14842. eCollection 2025 Feb.
2
Implications of ITCH-mediated ubiquitination of SIX1 on CDC27-cyclinB1 signaling in nasopharyngeal carcinoma.
Sci Rep. 2024 Oct 15;14(1):24140. doi: 10.1038/s41598-024-73239-5.
3
Radiomics in precision oncology: hype or ludum mutante.
BMC Med. 2023 Nov 28;21(1):465. doi: 10.1186/s12916-023-03165-2.
Zotero 插件